JOHNSON & Johnson said it would launch its incubator platform Johnson & Johnson Innovation JLABS in collaboration with Shanghai government to strengthen the local entrepreneurial ecosystem.

JLABS@Shanghai will be its first overseas site outside its eight locations across North America, and the 4,400-square-meter facility will be located in Shanghai’s Zhangjiang Hi-Tech Park and will open in the second quarter of 2019.

It is expected to support up to 50 life science and healthcare startups as well as focused on innovations across the entire healthcare spectrum, including pharmaceuticals, medical devices and consumers.

Vladimir Makatsaria, chairman of Johnson & Johnson China Group, said Shanghai has become a global hotspot for healthcare innovation.

JLABS@Shanghai will allow startups to access talent and mentors, large firms, research universities and capital.